1 Min Read
* BioLineRx reports third quarter 2017 financial results
* BioLine Rx ltd - qtrly loss per ordinary share $0.07 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.